₦airaland Forum

The trial of chloroquine and hydroxychloroquine as prophylaxis for COVID-19 in Nigeria has proved to be significantly effective.

A study, carried out by LiveWell Initiative in collaboration with frontline healthcare workers in the country, has undergone hypothesis testing among physicians, researchers, pharmacists and clinicians.

Preliminary data gathered from physicians were analyzed in this research, using the drugs for compassionate preventive treatment and for moderate to advance the treatment of COVID-19. It also recognised some self-medicating individuals who took advantage of the non-prescription remedy.

The chief executive officer of LWI, Bisi Bright, said in a statement that 123 volunteers were involved in the study of which 110 were on prophylaxis and 23 on treatment.

“The preliminary data also included a few self-medicating members of the public who did so under guidance. Out of the 110 on Prophylaxis, there were 76 men and 34 women to corroborate the fact.

“Our LWI Study Protocol recommends quinine for all COVID-19 Inpatients (oral for regular inpatients and intravenous for ICU Patients)” she said.

Quinine according to her, crosses the blood-brain barrier into the alveoli which gives it an added advantage over chloroquine and hydroxychloroquine in COVID-19 and picks up where CQ/ HCQ stop.

“That, of course, is in advanced COVID-19 treatment, especially during Cytokine Storm. The side effects are self- limiting. Reversible ototoxicity is the commonest but the benefit of administering it outweighs the risk of losing a life to COVID-19.

Read more===https://thestreetjournal.org/2020/06/breakthrough-nigerian-researchers-discover-drugs-for-covid-19-prevention/

'Blood brain barrier into the alveoli' .

very good.Oya Open schools,inter state

SirWarlock:
'Blood brain barrier into the alveoli' .

That's the kind of rubbish we get from Nigeria, where incompetent people take over positions they have no detailed knowledge about!